AI Reputation Analysis and Signal Evaluation – Bufferin by Genomma Lab USA Inc

B
Reputation Level
Medical Devices, Pharma & Biotech
59.3 Avg Reputation

Based on 784 businesses audited.

Brand AI Reputation

Medical Devices, Pharma & Biotech Reputation: Bufferin by Genomma Lab USA Inc (bufferin.com)

https://bufferin.com 📍 Industry: Medical Devices, Pharma & Biotech
47 Reputation / 100

Bufferin presents a classic ‘Legacy Brand in Decay’ profile, attempting to modernize with topical hemp trends and high-pressure FOMO widgets that undermine its 100-year scientific heritage. The glaring mismatch between metadata review counts and empty front-end review displays constitutes a critical failure in trust substance.

Info Density Power-words vs. Substance ratio.
18 60% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
16 80% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
4 20% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
5 33% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
4 27% Reputation
View evidence →

Medical Devices, Pharma & Biotech Reputation: Bufferin by Genomma Lab USA Inc (bufferin.com)

Reputation: 47 / 100

The site strongly aligns with the Pharmaceutical and OTC (Over-the-Counter) industry, focusing on pain management. It utilizes standard drug fact layouts and regulatory-style language (NSAID, analgesic, prostaglandins) appropriate for the category.

“The score of 47 is primarily driven by Trust and Proof failures (16/20), specifically the discrepancy in review data and the use of unverified social proof widgets. Stale corporate data from 2018 and the empty sameAs arrays in the schema further contributed to the Identity and Authority penalty.”

Verified Analysis Date: June 20, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result